Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
POLE4 pseudogene 1 (POLE4P1) is a **pseudogene** related by sequence to the functional gene *POLE4* (DNA polymerase epsilon 4, accessory subunit)[6]. Pseudogenes like POLE4P1 generally do not encode functional proteins and are not considered therapeutic targets, receptors, enzymes, or transporters[4][6]. While some pseudogenes can regulate their parental genes at the RNA level (for example, via competitive endogenous RNA activity), there is no specific evidence that POLE4P1 has such a function or disease association[4][6]. The functional *POLE4* gene product is a histone-fold protein involved in DNA replication and repair as part of DNA polymerase epsilon[1][5], but this does not apply to the pseudogene. **Context and supporting details:** - *POLE4* is a well-characterized DNA-binding protein and part of the DNA polymerase epsilon complex, but POLE4P1 is designated as a pseudogene and lacks protein-coding ability[6]. - Pseudogenes may sometimes influence gene regulation in cancer and other diseases[4], but there is no published evidence that POLE4P1 plays such a role. - No drugs, mechanisms of action, biomarkers, or notable safety concerns are reported for POLE4P1, as it is not a therapeutic target[6]. **Entry issues:** - Although POLE4P1 is a real pseudogene record[6], it is **not an active molecular target** for therapeutic or diagnostic development. - Searches for POLE4P1 return only that it is a pseudogene and do not identify any biological function, disease association, or role as a protein or RNA target. This target entry is considered "incorrect" for a therapeutic context as it refers to a pseudogene, not a protein or functional RNA target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on POLE4 pseudogene 1 (POLE4P1).